louisbrulenaudet/clinical-trials huggingface dataset:
Clinical trial NCT01326455: Caring for the Radial Artery Post-angiogram
Official title: Caring for the Radial Artery Post-angiogram: A Pilot Study on a Comparison of Three Methods of Compression
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Transradial Angiogram
Keywords: transradial
angiogram
device
Care of the radial artery post transradial angiogram
Lead sponsor: University of Alberta
Sponsor class: OTHER
First posted: 2011-03-30
Enrollment: 75
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: FACTORIAL
Primary purpose: TREATMENT

Brief summary: The purpose of this pilot study was to compare two devices and three methods for achieving hemostasis after a transradial angiogram while assessing vascular complications and time endpoints. The heart has traditionally been accessed through the femoral artery. However, in the last 20 years, the radial artery has gained more popularity among physicians and patients, thereby offering an alternative to the femoral approach. Various methods of applying compression to the radial puncture site have been used, but no research has been done to show what best practice is. In this case, best practice would be the most effective way of getting hemostasis while limiting complications and ensuring the efficient use of nursing and medical resources. It is hypothesized that statistically significant differences are seen in time to discharge in the fast-release Terumo and Clo-Sur P.A.D. groups, as compared with the control Terumo group, without increasing vascular complications.


Eligibility criteria: Inclusion Criteria:

* nonemergent
* outpatient

Exclusion Criteria:

* inpatients
* emergency patients
* booked angioplasty patients
* cognitive impairment
* those in whom the approach was initiated but aborted due to inability to puncture the radial artery

Primary outcomes:
measure: Bleeding Requiring Intervention After Initial Hemostasis Achieved
timeFrame: Assessed after initial hemostasis achieved
measure: Bleeding Requiring Intervention Post-CATH Day 1
timeFrame: Assessed post-CATH Day 1
Secondary outcomes:
measure: Time to Discharge
timeFrame: Assessed on day of angiogram.
measure: Hematoma or Bruising at Discharge
timeFrame: Assessed at discharge
measure: Hematoma or Bruising Post-CATH Day 1
timeFrame: Assessed post-CATH day 1.
measure: Radial Artery Occlusion Post-CATH
timeFrame: Assessed via plethysmography and palpation post-CATH
measure: Radial Artery Occlusion Post-CATH Day 1
timeFrame: Assessed via plethysmography and palpation post-CATH day 1.
Other outcomes:
Locations:
Study officials:
affiliation: University of Alberta
name: Colleen Norris, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Fech JC, Welsh R, Hegadoren K, Norris CM. Caring for the radial artery post-angiogram: a pilot study on a comparison of three methods of compression. Eur J Cardiovasc Nurs. 2012 Mar;11(1):44-50. doi: 10.1177/1474515111429656. Epub 2012 Jan 11.
Clinical trial NCT03393455: Obstetric & Pediatric Evolution Following Parental Refusal for Early Termination of Pregnancy Despite Fetal Risk
Official title: Evolution of Maternal & Infantile Health Following Parental Refusal of Termination of Pregnancy Despite Such Option Being Allowable by the Centre Pluridisciplinary de Diagnostic Prenatal (Interdisciplinary Center for Prenatal Diagnostics)
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Termination of Pregnancy
Keywords: Fetal pathology
Obstetrical outcome
Pediatric outcome
Lead sponsor: University Hospital, Montpellier
Sponsor class: OTHER
First posted: 2018-01-08
Enrollment: 211
Sex: FEMALE
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: RETROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Mother and child after refusal of termination of pregnancy despite serious fetal pathology

Brief summary: More and more parents decide to maintain pregnancy which could have been interrupted because of serious fetal pathologies.

In this observational study, the investigators examine obstetrical and pediatric evolution of these pregnancies, from 2006 to 2016 in Montpellier University Hospital.


Eligibility criteria: Inclusion criteria:

- refusal of termination of pregnancy despite serious fetal pathology

Exclusion criteria:

* termination of pregnancy
* termination of pregnancy not accepted by the Interdisciplinary Center for Prenatal Diagnostics

Primary outcomes:
measure: Apgar score at 5 minutes
timeFrame: 1 day
Secondary outcomes:
measure: health status of children
timeFrame: 1 day
Other outcomes:
Locations:
city: Montpellier
country: France
facility: Uhmontpellier
Study officials:
affiliation: University Hospital, Montpellier
name: florent FUCHS
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT04090255: Us vs Fluoroscopic Guided Renal Access
Official title: Ultrasonography Versus Fluoroscopic Guided Renal Access
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Hydronephrosis
Lead sponsor: Assiut University
Sponsor class: OTHER
First posted: 2019-09-16
Enrollment: 100
Sex: ALL
Minimum age (years): 6
Maximum age (years): 90
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: this present study is to compare the result of fluoroscopy, ultrasonography (US) in the guidance of percutaneous nephrostomy pcn .

Detailed description: investigators will enroll 100 patients who are candidates for PCN in the study. By simple random sampling technique, patients will be assigned to two patient groups (group 1, US-guided approach , group 2, fluoroscopy-guided approach.The end point of the study is the comparison of outcome of procedure including stone free rate, transfusion rate, operation time, access time, length of stay and complications.

Eligibility criteria: Inclusion Criteria:

* infected hydronephrotic kidney onen's grade 2-3
* obstructed good cortex with backpressure changes onen's grade 2-3 .
* Evaluation of function of asymptomatic hydronephrotic kidney thin cortex onen's grade 4

Exclusion Criteria:

* congenital anomalies of kidney
* patient underwent transplant or urinary diversion
* solitary kidney

Primary outcomes:
measure: Duration of puncture
timeFrame: Within the operation
measure: duration of operation
timeFrame: withen the operation
measure: Rate of success
timeFrame: withen the operation
Secondary outcomes:
measure: rate of Perioperative complication
timeFrame: withen the operation
measure: Haemoglobin concentration change
timeFrame: 24 hours post procedure
Other outcomes:
Locations:
city: Assiut
country: Egypt
facility: Mostafs Kamel Abdel Rahman
state: Sedfa
Study officials:
affiliation: Assiut
name: Fathy G Elanany, Prof
role: STUDY_DIRECTOR
affiliation: Assiut
name: Mohamed A Sayed, Prof
role: STUDY_DIRECTOR
affiliation: Assiut
name: Hosney M Bahnasawy, Ass Prof
role: STUDY_DIRECTOR
References:
citation: Chen X, Peng PX, He YH, Ding ZS, Wang JF, Tan YW, Zhou XF. [Evaluation and Comparison of SHA.LIN,S.T.O.N.E.Nephrolithometry Scoring System,and Clinical Research Office of the Endourological Society Nephrolithometry Nomogram for Predicting Stone Free Rate and Postoperative Outcomes after Percutaneous Nephrolithotomy]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019 Aug 30;41(4):492-500. doi: 10.3881/j.issn.1000-503X.10767. Chinese.
citation: Zanetti SP, Boeri L, Gallioli A, Talso M, Montanari E. Minimally invasive PCNL-MIP. Arch Esp Urol. 2017 Jan;70(1):226-234.
citation: Gulati M, Cheng J, Loo JT, Skalski M, Malhi H, Duddalwar V. Pictorial review: Renal ultrasound. Clin Imaging. 2018 Sep-Oct;51:133-154. doi: 10.1016/j.clinimag.2018.02.012. Epub 2018 Feb 16.
citation: Qiu Z, Yang Y, Zhang Y, Sun YC. Modified biological training model for percutaneous renal surgery with ultrasound and fluroscopy guidance. Chin Med J (Engl). 2011 May;124(9):1286-9.
Clinical trial NCT00907855: Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests
Official title: Clinical Role of the Duke Activity Status Index in the Selection of the Optimal Type of Stress Myocardial Perfusion Imaging Study in Patients With Known or Suspected Ischemic Heart Disease
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Ischemic Heart Disease
Keywords: Ischemic Heart Disease
Duke Activity Status Index
Stress Myocardial Perfusion Imaging
Lead sponsor: NYU Langone Health
Sponsor class: OTHER
Collaborators: name: Astellas Pharma Inc
First posted: 2009-05-25
Enrollment: 200
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients referred by their primary physician to the Nuclear Lab at NYU School of Medicine for stress myocardial perfusion imaging testing.

Brief summary: Cardiac stress testing with functional nuclear imaging is an invaluable technique in the diagnostic and prognostic evaluation of patients with known or suspected ischemic heart disease. Selection of the appropriate type of nuclear stress test: exercise stress Myocardial Perfusion Imaging (MPI) versus pharmacologic stress MPI is crucial for not only diagnostic accuracy and prognostic evaluation, but also for sound clinical decisions and resource utilization.

The Duke Activity Status Index (DASI) is a 12-item questionnaire that utilized self-reported physical work capacity to estimate peak metabolic equivalents (METs) and has been shown to be a valid measurement of functional capacity. The investigators hypothesized that the DASI may be the screening tool that evaluates functional capacity and guides selection of the optimal stress MPI study.


Eligibility criteria: Inclusion Criteria:

* Age \> 18

Exclusion Criteria:

* None

Primary outcomes:
Secondary outcomes:
Other outcomes:
Locations:
city: New York
country: United States
facility: Nuclear Cardiology/Stress Lab, NYU Cardiology Division
state: New York
Study officials:
affiliation: Division of Cardiology, New York University School of Medicine
name: Jennifer H. Mieres, MD
role: PRINCIPAL_INVESTIGATOR
affiliation: Division of Cardiology, New York University School of Medicine
name: Lawrence Phillips, MD
role: STUDY_DIRECTOR
References:
citation: Shaw LJ, Olson MB, Kip K, Kelsey SF, Johnson BD, Mark DB, Reis SE, Mankad S, Rogers WJ, Pohost GM, Arant CB, Wessel TR, Chaitman BR, Sopko G, Handberg E, Pepine CJ, Bairey Merz CN. The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol. 2006 Feb 7;47(3 Suppl):S36-43. doi: 10.1016/j.jacc.2005.03.080.
citation: Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, Cobb FR, Pryor DB. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989 Sep 15;64(10):651-4. doi: 10.1016/0002-9149(89)90496-7.
Clinical trial NCT02046655: Corifollitropin Alfa Compared to Daily rFSH in Poor Responders Undergoing ICSI
Official title: Corifollitropin Alfa Compared to Daily Rec FSH in Poor Responders Undergoing ICSI Using a GnRH Antagonist Protocol
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE4
Conditions: Subfertility
Lead sponsor: Aristotle University Of Thessaloniki
Sponsor class: OTHER
First posted: 2014-01-28
Enrollment: 80
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 45
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Corifollitropin alfa has been shown to result in significantly more oocytes compared to daily recombinant follicle stimulating hormone (recFSH) (Devroey et al., 2009), probably due to the higher circulating FSH activity during the first days of stimulation. For this reason, the use of corifollitropin alfa might be beneficial in poor responders in whom the number of oocytes retrieved is crucial for success.

The purpose of this study is to evaluate the effectiveness of corifollitropin alfa treatment compared to daily recFSH in terms of the number of oocytes retrieved in a defined population of poor responder patients undergoing intracytoplasmic sperm injection (ICSI) using gonadotrophin releasing hormone (GnRH) antagonists.


Eligibility criteria: Inclusion Criteria:

1. Proven poor responders of couples with an indication for COS
2. ≥ 18 and \< 45 years of age
3. BMI ≥ 18 and ≤ 32 kg/m2
4. Regular spontaneous menstrual cycle (24-35 days)
5. Availability of ejaculatory sperm (use of donated and/or cryo-preserved sperm is allowed)

Exclusion Criteria:

1. PGD or PGS
2. TESE

Primary outcomes:
measure: Total number of retrieved oocytes
timeFrame: 36 h after human chorionic gonadotrophin (hCG) administration
Secondary outcomes:
measure: Clinical pregnancy rate (evidence of intrauterine sac with fetal heart activity at 6-8 weeks of gestation)
timeFrame: At 6-8 weeks of gestation
measure: Number of embryos transferred
timeFrame: 2 days following oocyte retrieval
Other outcomes:
Locations:
city: Thessaloniki
country: Greece
facility: Unit for Human Reproduction, 1st Dept of Obstetrics and Gynaecology, Medical School, Aristotle University of Thessaloniki
Study officials:
affiliation: Unit for Human Reproduction, 1st Dept. of Obstetrics and Gynaecology, Medical School, Aristotle University of Thessaloniki
name: Efstratios M Kolibianakis, MD, MSc, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Kolibianakis EM, Venetis CA, Bosdou JK, Zepiridis L, Chatzimeletiou K, Makedos A, Masouridou S, Triantafillidis S, Mitsoli A, Tarlatzis BC. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial. Hum Reprod. 2015 Feb;30(2):432-40. doi: 10.1093/humrep/deu301. Epub 2014 Dec 9.
Clinical trial NCT03345355: MRI of Sacroiliac Joints: Evaluation of Accuracy of Dixon Sequences in the Diagnosis of Axial Spondyloarthritis
Official title: MRI of Sacroiliac Joints: Evaluation of Accuracy of Dixon Sequences in the Diagnosis of Axial Spondyloarthritis
Study type: OBSERVATIONAL
Overall status: TERMINATED
Conditions: Spondyloarthritis
Lead sponsor: Centre Hospitalier Universitaire de Nīmes
Sponsor class: OTHER
First posted: 2017-11-17
Enrollment: 5
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients with clinically-confirmed axial spondyloarthritis treated in the radiology services of the CHUs of Montpellier and Nimes

Brief summary: The investigators hypothesize that the T1 Dixon post-Gadolinium and T2 Dixon sequences will show good diagnostic performances for active sacroiliitis compared to the reference test (Short tau inversion recovery) and clinical-biological criteria, which will allow a better diagnosis of active sacroiliitis


Eligibility criteria: Inclusion Criteria:

* The patient must have given their free and informed consent and signed the consent form
* The patient must be a member or beneficiary of a health insurance plan
* The patient is at least 18 years old
* The patient has a clinically diagnosed axial spondyloarthritis (axSpA) (ASAS or AMOR classification)
* Patient has an active axSpA (BASDAI\>4)

Exclusion Criteria:

* The subject is participating in another study, or is in a period of exclusion determined by a previous study
* The subject refuses to sign the consent
* It is impossible to give the subject informed information
* The patient is under safeguard of justice or state guardianship
* The patient is pregnant or breastfeeding
* The patient has a contra-indication

Primary outcomes:
measure: Diagnostic performance of T1 Dixon post-Gadolinium and T2 Dixon for active sacroiliitis, according to subchondral edema status
timeFrame: Time 0
Secondary outcomes:
measure: Diagnosis of enthesitis from T1 Gadolinium Dixon sequence vs ASAS criteria
timeFrame: Time 0
measure: Diagnosis of synovitis from T2 Dixon and T1 Gadolinium Dixon sequences vs ASAS criteria
timeFrame: Time 0
measure: Diagnosis of chronic sacroiliite (erosion or chondral scler osis, or fatty spinal replacement) by T1 Dixon pre-Gadolinium
timeFrame: Time 0
measure: Diagnosis of chronic sacroiliite (erosion or chondral sclerosis, or fatty spinal replacement) by conventional sequences
timeFrame: Time 0
Other outcomes:
Locations:
city: Montpellier
country: France
facility: CHU Lapeyronie
city: Nîmes
country: France
facility: CHU Nimes
Study officials:
References:
Clinical trial NCT00200655: Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis
Official title: Safety and Efficacy of Pravastatin in Relapsing-remitting MS: a Double Blind Placebo Controlled Study
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE3
Conditions: Relapsing-remitting Multiple Sclerosis
Lead sponsor: Nantes University Hospital
Sponsor class: OTHER
First posted: 2005-09-20
Enrollment: 40
Sex: ALL
Minimum age (years): 18
Maximum age (years): 45
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Therapeutic strategies for multiple sclerosis (MS) are essentially based on the use of immunomodulatory agents such as interferon b and glatirmere acetate, but their efficacy is quite limited, they are not well tolerated and they have a very high cost. Recent works showed an immunomodulatory effects of HMG-CoA reductase inhibitors (the so-called "statins"). In experimental allergic encephalopathy, a murine model of MS, statins inhibit the onset and progression of the disease through a shift from Th1 towards Th2 cytokine production. Other in vitro studies suggest the ability of statins to inhibit the lymphocyte migration through the blood brain barrier. Furthermore, in an open labeled human study in MS, statin regimen was associated with a decreased lesional activity assessed by MRI. Statins are well tolerated drugs, used for many years, with a low cost and with a putative efficacy in MS. The investigators suggest to test the pravastatin safety and efficacy on MRI criteria in a double-blind, placebo-controlled study in 40 patients with a relapsing-remitting MS.


Eligibility criteria: Inclusion Criteria:

* Relapsing remitting MS with diagnosis defined by the McDonald criteria (McDonald et al., 2001) with no current disease modifying therapy (interferon, copaxone or immunosuppressant drugs) since at least 3 months and an EDSS score \< 5.
* At least one gadolinium positive lesion on the MRI of the selection phase is needed.
* No current statin therapy.
* Normal renal and hepatic biological tests.
* No current pregnancy

Primary outcomes:
measure: Number of gadolinium positive lesions at month 6 in each group.
timeFrame: at month 6 in each group
Secondary outcomes:
measure: Cumulated number of gadolinium positive lesions in each group after 6 months of follow-up
timeFrame: after 6 months of follow-up
measure: Number of new T2 lesions
Other outcomes:
Locations:
city: Nantes
country: France
facility: Nantes University Hospital
Study officials:
affiliation: Nantes UH
name: Philippe DAMIER, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT06674655: Motor Imagery Plus Therapeutic Exercise in Women With Menstrual Pain
Official title: Motor Imagery and Therapeutic Exercise on Sensorimotor Function in Women With Menstrual Pain: A Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Motor Imagery Training
Keywords: Motor Imagery
Therapeutic Exercise
Menstrual Pain
Lead sponsor: University of Valencia
Sponsor class: OTHER
First posted: 2024-11-05
Enrollment: 48
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 35
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The researchers will conduct a study that combines motor imagery with therapeutic exercise in women experiencing menstrual pain. Previous research suggests that motor imagery, when used alongside physical exercise, may help improve motor control and alleviate pain, potentially enhancing outcomes for individuals dealing with chronic pain conditions. Through this study, the investigators aim to explore the effectiveness of these interventions in targeting key variables such as pain perception, motor coordination, and overall quality of life, building on existing evidence of motor imagery's benefits in pain management.


Eligibility criteria: Inclusion Criteria:

* Women who have experienced menstrual pain for more than 6 months.
* Pain intensity rated higher than 3/10 on a pain scale.
* Participants do not take pain-relief medication during the study period.
* Ages between 18 and 35 years old

Exclusion Criteria:

* Current use of hormonal contraceptives or other treatments that affect menstrual cycles.
* Any chronic pain condition unrelated to menstrual pain (e.g., fibromyalgia, chronic low back pain).
* Diagnosed gynecological conditions such as endometriosis or pelvic inflammatory disease.
* Pregnancy or breastfeeding.
* Current use of psychoactive medications that could affect pain perception.
* Any significant psychiatric condition that could interfere with study participation.
* History of recent pelvic surgery (within the last 6 months).

Primary outcomes:
measure: Pain Intensity
timeFrame: Menstrual pain intensity will be assessed pre-intervention (T0), mid-intervention (T1-day 1, T2-day 2) and Post-intervention (T3-day 3).
Secondary outcomes:
measure: Lumbopelvic Motor Control
timeFrame: Lumbopelvic motor control will be assessed pre-intervention (T0), mid-intervention (T1-day 1, T2-day 2) and Post-intervention (T3-day 3).
measure: Pain Sensitivity
timeFrame: Pain sensitivity will be assessed pre-intervention (T0), mid-intervention (T1-day 1, T2-day 2) and Post-intervention (T3-day 3).
Other outcomes:
Locations:
city: València
country: Spain
facility: University of Valencia
state: Valènica
Study officials:
References:
Clinical trial NCT03442855: Non-Interventional, Multicenter Bicontact® E PMCF Study
Official title: Non-Interventional, Multicenter Bicontact® E PMCF Study
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Degenerative Osteoarthritis
Rheumatoid Arthritis
Femoral Neck Fractures
Femoral Head Necrosis
Keywords: Arthroplasty, Replacement, Hip
Lead sponsor: Aesculap AG
Sponsor class: INDUSTRY
First posted: 2018-02-22
Enrollment: 73
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients receiving primary THA:

Acute disorders of the hip that cannot be treated by other therapies:

* Degenerative osteoarthritis
* Rheumatic arthritis
* Joint fractures
* Femoral head necrosis

Brief summary: Prospective observational (non-interventional) cohort study, multi-centric in 5 study Centers in Japan to collect short term clinical and radiological results of the cementless Bicontact® E stem in a standard patient population used in routine clinical practice


Eligibility criteria: Inclusion Criteria:

* Indication for Bicontact E prosthesis THA
* Patients ≥ 18 years
* Patient not pregnant
* Written informed consent

Exclusion Criteria:

- Patients receiving a bipolar implantation

Primary outcomes:
measure: Clinical Results
timeFrame: 1 year
Secondary outcomes:
measure: Thigh Pain
timeFrame: 1 year
measure: X-Ray evaluation
timeFrame: 1 year
measure: (Serious) Adverse Events
timeFrame: 1 year
Other outcomes:
Locations:
city: Funabashi
country: Japan
facility: Funabashi Orthopedic Hospital
city: Niigata
country: Japan
facility: Niigata Bandai Hospital
city: Niigata
country: Japan
facility: Niigata Rinko Hospital
city: Niigata
country: Japan
facility: Niigata Univ. Medical & Dental Hospital
city: Niigata
country: Japan
facility: Saiseikai Niigata Second Hospital
Study officials:
References: